Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Annals of Nuclear Medicine
Erschienen in: Annals of Nuclear Medicine 12/2019

22.11.2019 | Editorial

An appreciation from the out-going editor-in-chief

verfasst von: Seigo Kinuya

Erschienen in: Annals of Nuclear Medicine | Ausgabe 12/2019

Einloggen, um Zugang zu erhalten

Excerpt

Annals of Nuclear Medicine (ANM), an official journal of the Japanese Society of Nuclear Medicine (JSNM), was launched in September, 1987 by the then board of directors with Professor Kinichi Hisada as the president. These predecessors endeavored to make ANM an international journal by eliminating all Japanese language from it. Now, ANM is recognized worldwide as an international platform for presenting top research results, highlighted by the fact that approximately 70% of submissions currently come from countries other than Japan. An impact factor of 0.503 was first assigned for ANM in 2001, and has steadily increased to 1.648 for the most recent one. I joined the editorial board in November 2006, was promoted to editor-in-chief in November 2009, and have held this position for the subsequent 10 years. …
Literatur
1.
Hosono M, Ikebuchi H, Nakamura Y, Nakamura N, Yamada T, Yanagida S, et al. Manual on the proper use of lutetium-177-labeled somatostatin analogue (Lu-177-DOTA-TATE) injectable in radionuclide therapy (2nd ed). Ann Nucl Med. 2018;32:217–35.CrossRef
2.
Escala Cornejo RA, García-Talavera P, Navarro Martin M, Pérez López B, García Muñoz M, Tamayo Alonso MP, et al. Large cell neuroendocrine carcinoma of the lung with atypical evolution and a remarkable response to lutetium Lu 177 dotatate. Ann Nucl Med. 2018;32:568–72.CrossRef
3.
Werner RA, Bundschuh RA, Bundschuh L, Javadi MS, Higuchi T, Weich A, et al. Molecular imaging reporting and data systems (MI-RADS): a generalizable framework for targeted radiotracers with theranostic implications. Ann Nucl Med. 2018;32:512–22.CrossRef
4.
Mair C, Warwitz B, Fink K, Scarpa L, Nilica B, Maffey-Steffan J, et al. Radiation exposure after 177Lu-DOTATATE and 177Lu-PSMA-617 therapy. Ann Nucl Med. 2018;32:499–502.CrossRef
5.
Şimşek DH, Şanlı Y, Kuyumcu S, Başaran B, Mudun A. 68Ga-DOTATATE PET–CT imaging in carotid body paragangliomas. Ann Nucl Med. 2018;32:297–301.CrossRef
6.
Watanabe M, Nakamoto Y, Koyasu S, Ishimori T, Yasoda A, Togashi K. The influence of elevated hormone levels on physiologic accumulation of 68Ga-DOTATOC. Ann Nucl Med. 2018;32:191–6.CrossRef
7.
Campbell SP, Baras AS, Ball MW, Kates M, Hahn NM, Bivalacqua TJ, et al. Low levels of PSMA expression limit the utility of 18F-DCFPyL PET/CT for imaging urothelial carcinoma. Ann Nucl Med. 2018;32:69–74.CrossRef
8.
Ringheim A, Campos Neto GC, Martins KM, Vitor T, da Cunha ML, Baroni RH. Reproducibility of standardized uptake values of same-day randomized 68Ga-PSMA-11 PET/CT and PET/MR scans in recurrent prostate cancer patients. Ann Nucl Med. 2018;32:523–31.CrossRef
9.
Komek H, Can C, Yilmaz U, Altindag S. Prognostic value of 68Ga PSMA I&T PET/CT SUV parameters on survival outcome in advanced prostate cancer. Ann Nucl Med. 2018;32:542–52.CrossRef
10.
Xu J, Li Y, Xu X, Zhang J, Zhang Y, Yu X, Huang D. Clinical application of 99mTc-HYNIC-TOC SPECT/CT in diagnosing and monitoring of pancreatic neuroendocrine neoplasms. Ann Nucl Med. 2018;32:446–52.CrossRef
11.
Kircher M, Herhaus P, Schottelius M, Buck AK, Werner RA, Wester H-J, et al. CXCR4-directed theranostics in oncology and inflammation. Ann Nucl Med. 2018;32:503–11.CrossRef
12.
Joraku A, Hatano K, Kawai K, Kandori S, Kojima T, Fukumitsu N, et al. Phase I/IIa PET imaging study with 89zirconium labeled anti-PSMA minibody for urological malignancies. Ann Nucl Med. 2019;33:119–27 Epub 2018 Nov 7.CrossRef
13.
Beshr R, Isohashi K, Watabe T, Naka S, Horitsugi G, Romanov V, et al. Preliminary feasibility study on differential diagnosis between radiation-induced cerebral necrosis and recurrent brain tumor by means of [18F]fluoro-borono-phenylalanine PET/CT. Ann Nucl Med. 2018;32:702–8.CrossRef
14.
Ishiwata K, Ebinuma R, Watanabe C, Hayashi K, Toyohara J. Reliable radiosynthesis of 4-[10B]borono-2-[18F]fluoro-L-phenylalanine with quality assurance for boron neutron capture therapy-oriented diagnosis. Ann Nucl Med. 2018;32:463–73.CrossRef
15.
Tsujikawa T, Narita N, Kanno M, Takabayashi T, Fujieda S, Okazawa H. Role of PET/MRI in oral cavity and oropharyngeal cancers based on the 8th edition of the AJCC cancer staging system: a pictorial essay. Ann Nucl Med. 2018;32:239–49.CrossRef
16.
Umeda T, Koizumi M, Fukai S, Miyaji N, Motegi K, Nakazawa S, et al. Evaluation of bone metastatic burden by bone SPECT/CT in metastatic prostate cancer patients: defining threshold value for total bone uptake and assessment in radium-223 treated patients. Ann Nucl Med. 2018;32:105–13.CrossRef
17.
Jones KM, Solnes LB, Rowe SP, Gorin MA, Sheikhbahaei S, Fung G, et al. Use of quantitative SPECT/CT reconstruction in 99mTc-sestamibi imaging of patients with renal masses. Ann Nucl Med. 2018;32:87–93.CrossRef
18.
Molina-García D, García-Vicente AM, Pérez-Beteta J, Amo-Salas M, Martínez-González A, Tello-Galán MJ, et al. Intratumoral heterogeneity in 18F-FDG PET/CT by textural analysis in breast cancer as a predictive and prognostic subrogate. Ann Nucl Med. 2018;32:379–88.CrossRef
19.
Parvez A, Tau N, Hussey D, Maganti M, Metser U. 18F-FDG PET/CT metabolic tumor parameters and radiomics features in aggressive non-Hodgkin's lymphoma as predictors of treatment outcome and survival. Ann Nucl Med. 2018;32:410–6.CrossRef
20.
Han S, Woo S, Suh CH, Kim YJ, Oh JS, Lee JJ. A systematic review of the prognostic value of texture analysis in 18F-FDG PET in lung cancer. Ann Nucl Med. 2018;32:602–10.CrossRef
21.
Nakajima K, Okuda K, Watanabe S, Matsuo S, Kinuya S, Toth K, et al. Artificial neural network retrained to detect myocardial ischemia using Japanese multicenter database. Ann Nucl Med. 2018;32:303–10.CrossRef
22.
Carrió I, Kinuya S. New section in EJNMMI and annals of nuclear medicine. Ann Nucl Med. 2016;30:593.CrossRef
Metadaten
Titel
An appreciation from the out-going editor-in-chief
verfasst von
Seigo Kinuya
Publikationsdatum
22.11.2019
Verlag
Springer Singapore
Erschienen in
Annals of Nuclear Medicine / Ausgabe 12/2019
Print ISSN: 0914-7187
Elektronische ISSN: 1864-6433
DOI
https://doi.org/10.1007/s12149-019-01423-z

Weitere Artikel der Ausgabe 12/2019

Annals of Nuclear Medicine 12/2019 Zur Ausgabe

Original Article

Association between carotid 18F-NaF and 18F-FDG uptake on PET/CT with ischemic vascular brain disease on MRI in patients with carotid artery disease

Original Article

PSMA SPECT/CT with 99mTc-MIP-1404 in biochemical recurrence of prostate cancer: predictive factors and efficacy for the detection of PSMA-positive lesions at low and very-low PSA levels

Original Article

Comparisons of 131I-rituximab treatment responses in patients with aggressive lymphoma and indolent lymphoma

Invited Review Article

From the respective expert viewpoints of the ANM specialty editors

Short Communication

Evaluation of PSMA expression changes on PET/CT before and after initiation of novel antiandrogen drugs (enzalutamide or abiraterone) in metastatic castration-resistant prostate cancer patients

Original Article

The evaluation of left ventricular dyssynchrony in hypertensive patients with a preserved systolic function undergoing gated SPECT myocardial perfusion imaging